Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors

[1]  B. Schackman,et al.  The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study , 2023, Harm Reduction Journal.

[2]  Annajane Yolken,et al.  Overdose Prevention Centers: An Essential Strategy to Address the Overdose Crisis. , 2022, JAMA network open.

[3]  D. Chokshi,et al.  First 2 Months of Operation at First Publicly Recognized Overdose Prevention Centers in US , 2022, JAMA network open.

[4]  D. Nash,et al.  Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022 , 2022, medRxiv.

[5]  E. Hall,et al.  Systematic review and meta-analysis to estimate the burden of fatal and non-fatal overdose among people who inject drugs , 2022, medRxiv.

[6]  K. Conway,et al.  Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study , 2021, JMIR public health and surveillance.

[7]  Pui Ying Chan,et al.  COVID-19 Outbreak — New York City, February 29–June 1, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[8]  C. Czeisler,et al.  Public Attitudes, Behaviors, and Beliefs Related to COVID-19, Stay-at-Home Orders, Nonessential Business Closures, and Public Health Guidance — United States, New York City, and Los Angeles, May 5–12, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[9]  D. D. Des Jarlais,et al.  The Impact of COVID-19 on Syringe Services Programs in the United States , 2020, AIDS and Behavior.

[10]  N. Dey.  COVID-19 Outbreak , 2020, Data Analytics for Pandemics.

[11]  J. Weiner,et al.  Predictors of Overdose Death Among High-Risk Emergency Department Patients With Substance-Related Encounters: A Data Linkage Cohort Study. , 2020, Annals of emergency medicine.

[12]  E. Wood,et al.  Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study , 2019, PLoS medicine.

[13]  D. Ciccarone.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. , 2019, The International journal on drug policy.

[14]  D. D. Des Jarlais,et al.  Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting , 2019, AIDS and Behavior.

[15]  D. D. Des Jarlais,et al.  Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City. , 2018, The International journal on drug policy.

[16]  N. S. Safadi,et al.  The Kessler psychological distress scale: translation and validation of an Arabic version , 2017, Health and Quality of Life Outcomes.

[17]  Shane R. Mueller,et al.  Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose? , 2017, The International journal on drug policy.

[18]  Raminta Daniulaityte,et al.  Overdose Deaths Related to Fentanyl and Its Analogs - Ohio, January-February 2017. , 2017, MMWR. Morbidity and mortality weekly report.

[19]  Julio S. G. Montaner,et al.  Prescription opioid use and non-fatal overdose in a cohort of injection drug users , 2015, The American journal of drug and alcohol abuse.

[20]  Emily A. Kuhl,et al.  The conceptual development of DSM-V. , 2009, The American journal of psychiatry.

[21]  R. Bluthenthal,et al.  Secondary Syringe Exchange Among Users of 23 California Syringe Exchange Programs , 2006, Substance use & misuse.

[22]  Douglas D. Heckathorn,et al.  Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hi , 2002 .

[23]  K. Seal,et al.  Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. , 2001, American journal of public health.

[24]  M. Langendam,et al.  The impact of harm-reduction-based methadone treatment on mortality among heroin users. , 2001, American journal of public health.

[25]  N. Smith,et al.  The Reassertion of Economics: 1990s Gentrification in the Lower East Side , 1999 .

[26]  S. Daniels,et al.  Good Samaritan acts. , 1999, Emergency medicine clinics of North America.

[27]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[28]  B. Stepherson,et al.  Heroin sniffers: between two worlds. , 1988, Journal of psychoactive drugs.

[29]  J. Zibbell,et al.  Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. , 2019, The International journal on drug policy.

[30]  A. Baldacchino,et al.  Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis. , 2014, Drug and alcohol dependence.

[31]  M. Valenstein,et al.  Risk of death from accidental overdose associated with psychiatric and substance use disorders. , 2012, The American journal of psychiatry.

[32]  P. Griffiths,et al.  Evaluation of a Brief Intervention to Prevent Initiation into Injecting , 1998 .

[33]  R. Bluthenthal,et al.  Syringe exchange as a social movement: a case study of harm reduction in Oakland, California. , 1998, Substance use & misuse.